Why Investors Shouldn't Be Surprised By InterCure Ltd.'s (TLV:INCR) 29% Share Price Plunge
Jan 14
Have your own idea? Try our Stock Screener
Israeli (TA) Pharma Industry Analysis
UpdatedApr 07, 2026
DataAggregated Company Financials
Companies6
- 7D-0.5%
- 3M-12.0%
- 1Y-33.1%
- YTD-10.0%
The Pharma is pretty flat in the last 7 days, but Rekah Pharmaceutical Industry has stood out, gaining 3.3%. Unfortunately though, the industry is down 33% over the past 12 months.
Industry Valuation and Performance
Has the Israeli Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 07 Apr 2026 | ₪414.0m | ₪701.3m | -₪178,314,654.00 | 56.4x | -2.3x | 0.6x |
| Thu, 05 Mar 2026 | ₪465.2m | ₪706.6m | -₪88,007,302.30 | 7x | -5.3x | 0.7x |
| Sat, 31 Jan 2026 | ₪461.0m | ₪706.6m | -₪88,080,774.90 | 6.5x | -5.2x | 0.7x |
| Mon, 29 Dec 2025 | ₪472.4m | ₪706.6m | -₪88,387,669.30 | 5.8x | -5.3x | 0.7x |
| Wed, 26 Nov 2025 | ₪546.3m | ₪720.3m | -₪94,777,954.90 | 6.4x | -5.8x | 0.8x |
| Fri, 24 Oct 2025 | ₪593.5m | ₪720.3m | -₪92,699,445.80 | 6.9x | -6.4x | 0.8x |
| Sun, 21 Sep 2025 | ₪554.7m | ₪716.6m | -₪84,397,418.60 | 6.8x | -6.6x | 0.8x |
| Tue, 19 Aug 2025 | ₪571.3m | ₪716.7m | -₪67,200,958.00 | 29.1x | -8.5x | 0.8x |
| Thu, 17 Jul 2025 | ₪567.8m | ₪716.7m | -₪71,549,063.80 | 30x | -7.9x | 0.8x |
| Sat, 14 Jun 2025 | ₪580.7m | ₪716.7m | -₪72,617,509.60 | 31.1x | -8x | 0.8x |
| Mon, 12 May 2025 | ₪594.4m | ₪732.8m | -₪81,881,516.00 | 15x | -7.3x | 0.8x |
| Wed, 09 Apr 2025 | ₪531.2m | ₪766.6m | -₪81,466,664.00 | 13.9x | -6.5x | 0.7x |
| Fri, 07 Mar 2025 | ₪657.5m | ₪828.6m | -₪180,626,229.80 | 21.3x | -3.6x | 0.8x |
| Sun, 02 Feb 2025 | ₪661.5m | ₪828.6m | -₪180,269,495.00 | 20.9x | -3.7x | 0.8x |
| Tue, 31 Dec 2024 | ₪649.7m | ₪828.6m | -₪181,230,114.20 | 20.1x | -3.6x | 0.8x |
| Thu, 28 Nov 2024 | ₪588.6m | ₪828.6m | -₪181,216,124.60 | 21.4x | -3.2x | 0.7x |
| Sat, 26 Oct 2024 | ₪637.8m | ₪808.7m | -₪206,236,933.40 | 22.6x | -3.1x | 0.8x |
| Mon, 23 Sep 2024 | ₪669.3m | ₪808.7m | -₪206,038,149.00 | 22.1x | -3.2x | 0.8x |
| Wed, 21 Aug 2024 | ₪624.0m | ₪901.7m | -₪251,977,410.20 | n/a | -2.5x | 0.7x |
| Fri, 19 Jul 2024 | ₪723.1m | ₪901.7m | -₪261,119,387.20 | n/a | -2.8x | 0.8x |
| Sun, 16 Jun 2024 | ₪696.5m | ₪901.7m | -₪257,473,788.00 | n/a | -2.7x | 0.8x |
| Tue, 14 May 2024 | ₪829.1m | ₪886.2m | -₪261,237,908.00 | n/a | -3.2x | 0.9x |
| Thu, 11 Apr 2024 | ₪758.6m | ₪956.4m | -₪180,578,388.00 | 20.5x | -4.2x | 0.8x |
| Sat, 09 Mar 2024 | ₪648.9m | ₪972.3m | -₪206,749,172.00 | 14.6x | -3.1x | 0.7x |
| Mon, 05 Feb 2024 | ₪544.9m | ₪972.3m | -₪212,629,474.00 | 10x | -2.6x | 0.6x |
| Wed, 03 Jan 2024 | ₪568.1m | ₪972.3m | -₪212,471,501.00 | 10.4x | -2.7x | 0.6x |
| Fri, 01 Dec 2023 | ₪595.6m | ₪972.3m | -₪214,146,010.00 | 10x | -2.8x | 0.6x |
| Sun, 29 Oct 2023 | ₪621.5m | ₪958.8m | -₪215,224,698.00 | 9.6x | -2.9x | 0.6x |
| Tue, 26 Sep 2023 | ₪681.9m | ₪958.8m | -₪209,747,140.00 | 13.3x | -3.3x | 0.7x |
| Thu, 24 Aug 2023 | ₪653.0m | ₪920.2m | -₪192,182,930.00 | 8.2x | -3.4x | 0.7x |
| Sat, 22 Jul 2023 | ₪679.1m | ₪918.8m | -₪125,226,143.00 | 8.7x | -5.4x | 0.7x |
| Mon, 19 Jun 2023 | ₪772.2m | ₪918.8m | -₪123,743,970.00 | 11x | -6.2x | 0.8x |
| Wed, 17 May 2023 | ₪833.6m | ₪906.2m | -₪134,999,537.00 | 12.5x | -6.2x | 0.9x |
| Fri, 14 Apr 2023 | ₪806.9m | ₪855.1m | -₪87,449,373.00 | 9.8x | -9.2x | 0.9x |
Price to Earnings Ratio
-9.2x
Current Industry PE
- Investors are pessimistic on the Israeli Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading close to its 3-year average PS ratio of 0.75x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have deteriorated over the last three years.
- Revenues have also declined 6.4% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Trends
Which industries have driven the changes within the Israeli Healthcare industry?
| IL Market | 4.45% | |
| Healthcare | 3.88% | |
| Pharma | -0.46% | |
| Pharma | -0.46% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| REKA Rekah Pharmaceutical Industry | ₪12.11 | 3.3% +₪4.5m | 1.7% | PS0.5x | |
| TKUN Tikun Olam-Cannbit Pharmaceuticals | ₪23.23 | 18.5% +₪3.1m | -37.0% | PS0.6x | |
| YBRD Y.B Urban Renewal - Residential Development | ₪7.23 | 2.5% +₪773.6k | 0.7% | PB4.7x |